GYN 4: phase I study of BIBF 1120 in combination with paclitaxel/carboplatin in patients with advanced gynecological malignancies

被引：0
|
作者：
Huober, J. [1 ]
Pfisterer, J. [2 ]
Wimberger, P. [3 ]
Loibl, S. [4 ]
Stopfer, P. [5 ]
du Bois, A. [6 ]
机构：
[1] Kantonsspital St Gallen, Senolog Zentrum, St Gallen, Switzerland
[2] Univ Klinikum Schleswig Holstein, Kiel, Germany
[3] Univ Frauenklin, Essen, Germany
[4] Univ Frauenklin Frankfurt Main, Frankfurt, Germany
[5] Boehringer Ingelheim Pharm GmbH & Co, Biberach, Germany
[6] Klin Gynakol & Gynakol Onkol, Dr Horst Schmidt Klin GmbH, HSK, Wiesbaden, Germany
来源：
GEBURTSHILFE UND FRAUENHEILKUNDE | 2008年 / 68卷
关键词：
D O I：
暂无
中图分类号：
R71 [妇产科学];
学科分类号：
100211 ;
摘要：
引用
收藏
页码：S11 / S11
页数：1
相关论文
共 50 条
  • [1] GYN 4: A phase I dose escalation and pharmacokinetic study of BIBF 1120 in combination with paclitaxel/carboplatin in patients with advanced gynecological malignancies
    Belau, A.
    Huober, J.
    Pfisterer, J.
    Wimberger, P.
    Loibl, S.
    Stopfer, P.
    Kaiser, R.
    Reichardt, V.
    du Bois, A.
    ONKOLOGIE, 2008, 31 : 105 - 105
  • [2] A phase I dose escalation and pharmacokinetic study of BIBF 1120 in combination with paclitaxel and carboplatin in patients with advanced gynecological malignancies
    Harter, P.
    Huober, J.
    Pfisterer, J.
    Wimberger, P.
    Loibl, S.
    Stopfer, P.
    Kaiser, R.
    Reichardt, V.
    du Bois, A.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
  • [3] A phase I open-label dose-escalation study of oral BIBF 1120 combined with standard paclitaxel and carboplatin in patients with advanced gynecological malignancies
    du Bois, A.
    Huober, J.
    Stopfer, P.
    Pfisterer, J.
    Wimberger, P.
    Loibl, S.
    Reichardt, V. L.
    Harter, P.
    ANNALS OF ONCOLOGY, 2010, 21 (02) : 370 - 375
  • [4] Weekly paclitaxel in combination with carboplatin: A phase I study in advanced malignancies
    Belani, CP
    Ramanathan, RK
    SEMINARS IN ONCOLOGY, 1999, 26 (06) : 63 - 63
  • [5] PHASE I STUDY OF NINTEDANIB (BIBF 1120) IN EUROPEAN PATIENTS WITH ADVANCED HEPATOCELLULAR CARCINOMA
    Palmer, D.
    Loembe, A. B.
    Studeny, M.
    Hocke, J.
    Meyer, T.
    ANNALS OF ONCOLOGY, 2012, 23 : 245 - 245
  • [6] Phase I Study of the Angiogenesis Inhibitor BIBF 1120 in Patients with Advanced Solid Tumors
    Mross, Klaus
    Stefanic, Martin
    Gmehling, Daniela
    Frost, Annette
    Baas, Franziska
    Unger, Clemens
    Strecker, Ralph
    Henning, Juergen
    Gaschler-Markefski, Birgit
    Stopfer, Peter
    de Rossi, Lothar
    Kaiser, Rolf
    CLINICAL CANCER RESEARCH, 2010, 16 (01) : 311 - 319
  • [7] A phase I study of veliparib (ABT-888) in combination with carboplatin and paclitaxel in advanced solid malignancies
    Appleman, Leonard Joseph
    Beumer, Jan Hendrik
    Jiang, Yixing
    Puhalla, Shannon
    Lin, Yan
    Owonikoko, Taofeek Kunle
    Harvey, R. Donald
    Stoller, Ronald
    Petro, Daniel P.
    Tawbi, Hussein Abdul-Hassan
    Argiris, Athanassios
    Strychor, Sandra
    Kiesel, Brian
    Chu, Edward
    Shepherd, Stacie Peacock
    Giranda, Vincent L.
    Chen, Alice P.
    Belani, Chandra Prakash
    Ramalingam, Suresh S.
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
  • [8] Pharmacokinetic (PK) analysis of a phase I study of continuous oral treatment with the angiokinase inhibitor BIBF 1120, in combination with carboplatin and paclitaxel in patients with advanced non-small cell lung cancer (NSCLC)
    Camidge, D. R.
    Conkling, P.
    Stephenson, J. J.
    Glassman, P. M.
    Zhao, Y.
    Kaiser, R.
    Stopfer, P.
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [9] Phase I study of elisidepsin (Irvalec®) in combination with carboplatin or gemcitabine in patients with advanced malignancies
    Francois Goldwasser
    Sandrine Faivre
    Jerome Alexandre
    Cinthya Coronado
    Eva M. Fernández-García
    Carmen M. Kahatt
    Pilar García Paramio
    Jorge Luis Iglesias Dios
    Bernardo Miguel-Lillo
    Eric Raymond
    Investigational New Drugs, 2014, 32 : 500 - 509
  • [10] A Phase I and Pharmacokinetic Study of Ixabepilone in Combination with Carboplatin in Patients with Advanced Solid Malignancies
    Plummer, Ruth
    Woll, Penella
    Fyfe, David
    Boddy, Alan V.
    Griffin, Melanie
    Hewitt, Paula
    Carmichael, James
    Namouni, Fouad
    Cohen, Marvin
    Verrill, Mark
    CLINICAL CANCER RESEARCH, 2008, 14 (24) : 8288 - 8294
12345